MyAverix Finance
F · Healthcare
Enzymatica AB (EN9)
Drug Manufacturers - Specialty & Generic
Enzymatica AB (EN9) is listed on F in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-29, reported market cap is $48.43M, P/E ratio is 18.00, net margin is -96.3%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for EN9
Enzymatica AB (EN9) — FAQ
What is Enzymatica AB's market cap?
Enzymatica AB (EN9) has a reported market cap of $48.43M (data as of 2026-03-29).
What is EN9's P/E ratio?
The price-to-earnings (P/E) ratio for Enzymatica AB (EN9) is 18.00 (data as of 2026-03-29).
Does Enzymatica AB pay a dividend?
Dividend yield is not available in the current snapshot for Enzymatica AB (EN9). Check the MyAverix Finance app for the latest dividend data.
What sector is Enzymatica AB in?
Enzymatica AB (EN9) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is EN9 listed on?
EN9 is listed on F.
What is Enzymatica AB's net margin?
Enzymatica AB (EN9) reports a net margin of -96.3% (data as of 2026-03-29).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.